NCT00080743View on ClinicalTrials.gov

Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer

PHASE2CompletedINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

January 31, 2004

Primary Completion Date

April 30, 2005

Study Completion Date

November 30, 2005

Conditions
Breast Cancer
Interventions
DRUG

gefitinib

250 mg po once daily

DRUG

tamoxifen citrate

20 mg po once daily

DRUG

Placebo

One pill po once daily

Trial Locations (1)

03756

Norris Cotton Cancer Center at Dartmouth-Hitchcock Medical Center, Lebanon

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Norris Cotton Cancer Center

OTHER

lead

Dartmouth-Hitchcock Medical Center

OTHER

NCT00080743 - Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer | Biotech Hunter | Biotech Hunter